Abstract
Emergency physicians frequently utilize computed tomography (CT) to evaluate patients with abdominal pain. Acute causes of abdominal pain may be difficult to diagnose based on history and physical exam alone, and CT imaging is the modality of choice for most etiologies. When ordering a CT, physicians must decide whether to utilize intravenous or oral contrast. It is important to understand the benefits of a contrast-enhanced CT and weigh this against the risks of the contrast medium.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
FormalPara Pearls and Pitfalls-
Contrast reactions occur infrequently, and serious, life-threatening reactions are extremely rare.
-
Evidence has challenged the clinical relevance of contrast-induced nephropathy.
-
The risks and benefits of contrast should be considered when choosing whether to utilize a contrast-enhanced CT.
-
Oral contrast should not routinely be used in abdominal computed tomography.
In 2014, approximately 6% of all patients presenting to United States emergency departments had computed tomography (CT) of their abdomen and pelvis. Abdominal pain was the most common presenting complaint, making up nearly 8% of all visits [1]. History, physical, and laboratory evaluation are often not enough to rule out or diagnose a dangerous etiology of abdominal pain. Therefore, patients presenting with focal abdominal pain or concern for a surgical cause of pain must be considered for imaging.
General Considerations
CT is the imaging test of choice for most acute abdominal pain (with exception of abdominal aortic aneurysm, acute cholecystitis, or gonadal pathology, in which ultrasound is first line). It has a high sensitivity and specificity for many serious causes of abdominal pain including appendicitis, obstruction, perforation, diverticulitis, and bowel ischemia. However, the use of CT must be weighed against risk of radiation exposure especially in younger patients [2, 3]. Clinicians must also weigh benefits and drawbacks of contrast-enhanced CT.
Intravenous (IV) contrast is beneficial for its opacification of vascular structures and solid abdominal and pelvic organs. IV contrast in abdominal imaging is recommended for nearly all indications, with the notable exception of renal colic evaluation [4,5,6,7]. There are two primary barriers to patients receiving IV contrast in the emergency department: concern for an allergic-type contrast reaction and contrast-induced nephropathy. The decision to utilize IV contrast requires a risk-benefit analysis by the ordering physician, which requires a reasonable understanding of the risks of each of these entities.
Allergic-Type Contrast Reactions
Contrast reactions are not IgE mediated and therefore not true allergic reactions. The significance is that a patient may have a contrast reaction on their first exposure to iodinated contrast, as no sensitization is required. Likewise, a patient who has had a previous contract reaction may not have subsequent reactions. While it is recognized that a previous contrast reaction is a risk factor for future reactions, this rate of recurrence may be lower than expected. One study found in patients with a reported history of contrast reaction, only 7.4% had another adverse reaction when given IV contrast. Very few (0.02%) of these reactions were anaphylactoid and none were fatal [8].
Physicians may overestimate the incidence of contrast reactions. Historical studies which were performed using high-osmolar contrast agents, as compared to the low- and iso-osmolar agents used in current practice, may overinflate the suspected risk of reactions. Studies using these modern contrast agents have shown overall reaction rates of 0.6–1.5%, with very few (0.03–0.05%) of these being anaphylactoid or life-threatening [8,9,10,11]. Another study of the incidence of allergic-like contrast reactions specifically in the emergency department found an overall adverse reaction rate of 0.2% with no serious reactions [11].
Shellfish and “Iodine” Allergies
It is worth addressing a long-standing myth that someone with a reported shellfish allergy is unable to receive IV contrast. Allergies to shellfish do not increase the risk of contrast reaction over any other allergy. There is also the concern of patients reporting an “iodine allergy.” Iodine is not an allergen, as it is found intrinsically in the human body as well as in table salt [7, 12].
Contrast-Induced Nephropathy
Contrast-induced nephropathy is typically defined as signs of acute kidney injury (AKI) within 48 h of contrast administration and has been called the third most common cause of in-hospital AKI [13, 14]. More recent evidence has shown a lack of association between contrast use and AKI [15,16,17,18,19]. While not definitive, the discrepancy between previous and current evidence may be that in instances where contrast was attributed causation for AKI, other coexisting factors, such as underlying illness, nephrotoxic drugs, and hypovolemia, may have contributed. Recent studies have likely been more regimented about controlling for these cofounders.
American College of Radiology (ACR) guidelines state that assessment of renal function prior to contrast use may be warranted in patients who are of age greater than 60, have history of renal disease, have history of hypertension requiring treatment, have history of diabetes mellitus, or are currently using metformin. For all other patients, a baseline serum creatinine measurement is not required prior to contrast administration. For patients who do have an assessment of renal function, the ACR recommends a threshold of eGFR <30 for risk of nephropathy [7].
Value of Oral Contrast
Oral contrast has not been shown to significantly improve the accuracy of CT in diagnosing the vast majority of acute abdominopelvic abnormalities in the emergency department [20]. Studies of emergency departments after the elimination of the routine use of oral contrast showed decrease in wait times, an average of 97 min in one study, without an increase in bouncebacks or missed findings [21, 22]. With the exception of inflammatory bowel disease and patients post-gastric bypass, the ACR does not strongly recommend the use of oral contrast in any of the indications for acute abdominal imaging [5, 6, 20]. There have been many studies that do not show a benefit in the use of oral contrast in the evaluation of appendicitis [23,24,25,26], and the ACR recommends against the use of oral contrast when evaluating for bowel obstruction [6, 7]. Oral contrast should not routinely be used in the CT evaluation of abdominal pain in the emergency department.
Suggested Resource
-
ACR Manual on Contrast Media. https://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/Resources/Contrast-Manual/Contrast_Media.pdf.
References
National Hospital Ambulatory Medical Care Survey: 2014 Emergency Department. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2017. Available at: https://www.cdc.gov/nchs/data/nhamcs/web_tables/2014_ed_web_tables.pdf.
Gans S, Pols M, Stoker J, Boermeester M. Guideline for the diagnostic pathway in patients with acute abdominal pain. Dig Surg. 2015;32:23–31.
Stoker J, Randen A, Lameris W, Boermeester M. Imaging patients with acute abdominal pain. Radiology. 2009;253(1):31–46.
Rawson JV, Pelletier AL. When to order a contrast-enhanced CT. Am Fam Physician. 2013;88(5):312–6.
Broder JS, Hamedani AG, Liu SW, Emerman CL. Emergency department contrast practices for abdominal/pelvic computed tomography-a national survey and comparison with the American college of radiology appropriateness criteria(®). J Emerg Med. 2013;44(2):423–33.
ACR Appropriateness Criteria. Reston, VA: American College of Radiology; 2017. Available at: https://www.acr.org/Quality-Safety/Appropriateness-Criteria.
American College of Radiology. ACR manual on contrast media. Version 10.3. Reston, VA: American College of Radiology; 2017.
Kopp AF, Mortele KJ, Cho YD, Palkowitsch P, Bettmann MA, Claussen CD. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients. Acta Radiol. 2008;49(8):902–11.
Häussler MD. Safety and patient comfort with iodixanol: a postmarketing surveillance study in 9515 patients undergoing diagnostic CT examinations. Acta Radiol. 2010;51(8):924–33.
Wang CL, Cohan RH, Ellis JH, Caoili EM, Wang G, Francis IR. Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR Am J Roentgenol. 2008 Aug;191(2):409–15.
Gottumukkala RV, Glover M 4th, Yun BJ, Sonis JD, Kalra MK, Otrakji A, Raja AS, Prabhakar AM. Allergic-like contrast reactions in the ED: incidence, management,and impact on patient disposition. Am J Emerg Med. 2017;36(5):825–8.
Schabelman E, Witting M. The relationship of radiocontrast, iodine, and seafood allergies: a medical myth exposed. J Emerg Med. 2010;39(5):701–7.
Tublin ME, Murphy ME, Tessler FN. Current concepts in contrast media-induced nephropathy. AJR. 1998;171:933–9.
Wichmann JL, Katzberg RW, Litwin SE, Zwerner PL, De Cecco CN, Vogl TJ, Costello P, Schoepf UJ. Contrast-induced nephropathy. Circulation. 2015;132(20):1931–6.
McDonald JS, McDonald RJ, Comin J, et al. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. Radiology. 2013;267(1):119–28.
Davenport MS, Khalatbari S, Cohan RH, Dillman JR, Myles JD, Ellis JH. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. Radiology. 2013;268(3):719–28.
McDonald JS, McDonald RJ, Carter RE, Katzberg RW, Kallmes DF, Williamson EE. Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology. 2014;271(1):65–73.
Hinson JS, Ehmann MR, Fine DM, Fishman EK, Toerper MF, Rothman RE, Klein EY. Risk of acute kidney injury after intravenous contrast media administration. Ann Emerg Med. 2017;69(5):577–586.e4.
Aycock RD, Westafer LM, Boxen JL, Majlesi N, Schoenfeld EM, Bannuru RR. Acute kidney injury after computed tomography: a meta-analysis. Ann Emerg Med. 2017;71(1):44–53.e4.
Kielar AZ, Patlas MN, Katz DS. Oral contrast for CT in patients with acute non-traumatic abdominal and pelvic pain: what should be its current role? Emerg Radiol. 2016;23(5):477–81.
Razavi SA, Johnson JO, Kassin MT, Applegate KE. The impact of introducing a no oral contrast abdominopelvic CT examination (NOCAPE) pathway on radiology turn around times, emergency department length of stay, and patient safety. Emerg Radiol. 2014;21(6):605–13.
Levenson RB, Camacho MA, Horn E, Saghir A, McGillicuddy D, Sanchez LD. Eliminating routine oral contrast use for CT in the emergency department: impact on patient throughput and diagnosis. Emerg Radiol. 2012;19(6):513–7.
Anderson BA, Salem L, Flum DR. A systematic review of whether oral contrast is necessary for the computed tomography diagnosis of appendicitis in adults. Am J Surg. 2005;190(3):474–8.
Drake FT, Alfonso R, Bhargava P, Cuevas C, Dighe MK, Florence MG, Johnson MG, Jurkovich GJ, Steele SR, Symons RG, Thirlby RC, Flum DR, Writing Group for SCOAP-CERTAIN. Enteral contrast in the computed tomography diagnosis of appendicitis: comparative effectiveness in a prospective surgical cohort. Ann Surg. 2014;260(2):311–6.
Kepner AM, Bacasnot JV, Stahlman BA. Intravenous contrast alone vs intravenous and oral contrast computed tomography for the diagnosis of appendicitis in adult ED patients. Am J Emerg Med. 2012;30(9):1765–73.
Laituri CA, Fraser JD, Aguayo P, Fike FB, Garey CL, Sharp SW, Ostlie DJ, St Peter SD. The lack of efficacy for oral contrast in the diagnosis of appendicitis by computed tomography. J Surg Res. 2011;170(1):100–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Repanshek, Z., Kingsley, E. (2019). Evaluation of Acute Abdominal Pain with Computed Tomography. In: Graham, A., Carlberg, D.J. (eds) Gastrointestinal Emergencies. Springer, Cham. https://doi.org/10.1007/978-3-319-98343-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-98343-1_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98342-4
Online ISBN: 978-3-319-98343-1
eBook Packages: MedicineMedicine (R0)